Featured Research

from universities, journals, and other organizations

Muscular heart failure patients may have a better chance at survival, study suggests

Date:
July 22, 2010
Source:
University of Alberta
Summary:
Heart failure patients with more muscle have the potential to increase their length of life, new research has found.

University of Alberta research has discovered heart failure patients with more muscle have the potential to increase their length of life.

Antigone Oreopoulos, a researcher from the U of A's School of Public Health, studied 140 patients with heart failure. Study participants underwent a special scan to measure their muscle mass and body fat.

Oreopoulos' research found that having more muscle was associated with better nutritional status and lower severity of heart failure, while higher body fat was associated with increased inflammation and reduced exercise capacity. This suggests that in patients with heart failure having more muscle mass and lower fat may be beneficial.

Oreopoulos' research was published this month in the journal Mayo Clinic Proceedings.

The study also discovered that testing just the body mass index (BMI) of heart failure patients doesn't accurately measure their body fat status. Oreopoulos found 41 per cent of the participants were inaccurately classified by BMI. Many who had a high body weight but not high body fat were mislabelled as obese and others who did not weigh a lot but had a high amount of body fat were mislabelled as normal by BMI. Oreopoulos says this research has direct implications for weight management guidelines and adds that to date there is a shortage of evidence to guide a clinician's decision about when to recommend weight loss to a patient with heart failure.

While this study provides potential explanations of how muscle and fat could possibly play a role in the survival of heart failure patients, Oreopoulos says there isn't enough evidence to make specific recommendations. Her team plans to conduct treatment studies that examine the effects of intentional weight gain and loss on the survival and quality of life in these patients.


Story Source:

The above story is based on materials provided by University of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University of Alberta. "Muscular heart failure patients may have a better chance at survival, study suggests." ScienceDaily. ScienceDaily, 22 July 2010. <www.sciencedaily.com/releases/2010/07/100721133215.htm>.
University of Alberta. (2010, July 22). Muscular heart failure patients may have a better chance at survival, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/07/100721133215.htm
University of Alberta. "Muscular heart failure patients may have a better chance at survival, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/07/100721133215.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins